Genome editing (also known as gene editing) refers to a set of technologies that allow scientists to alter an organism's DNA. These technologies allow for the addition, removal, or modification of genetic material at specific points in the genome. There have been several ways by which genome editing developed. Genome editing tools allow scientists to alter DNA, resulting in changes in physical characteristics such as physical features and disease risk. To achieve so, scientists employ a variety of technologies. These devices work like scissors, cutting DNA at a precise location. The DNA that was sliced can then be removed, added to, or replaced by scientists.
The microbiome is made up of all of a microbiota's genetic material (the entire collection of microorganisms in a specific niche, such as the human gut). This is also referred to as the microbiota's metagenome. The microbiome is the genetic material of all microbes that reside on and inside the human body, including bacteria, fungi, protozoa, and viruses. The total number of genes in a person's microbiome is 200 times greater than the number of genes in the human genome. It's possible that the microbiota weighs up to five pounds. Human development, immunity, and nutrition are all dependent on the microbiome.
During carcinogenesis, gene mutations occur in both the non-coding and coding regions, and amino acid sequence variations produced by mutations in the coding region might result in proteins that are not found in normal cells. These proteins have the ability to activate the immune system, causing it to target cancer cells. Neoantigens are mutated antigens that are only expressed on the surface of cancerous cells and are not found on the surface of normal cells. Viral infection, alternative splicing, and gene rearrangement can all generate neoantigens.
Title : Copper (II) complexes as potential anticancer agents
Salah S Massoud, University of Louisiana, United States
Title : Pharmacogenomics: current status and future directions
Matthias Schwab, University of Tübingen, Germany
Title : Talus bone of the hindfoot: Unique anatomy and an important clinical implication
Abdelmonem Awad Hegazy, Zarqa University, Jordan
Title : The use of anti seizure medication therapeutic blood level determination to personalise the treatment of epileptic seizures especially in patients attending the accident and emergency department
Roy Gary Beran, University of New South Wales, Australia
Title : Effect of Fluvoxamine on Interluekin-6 level of COVID-19 patients, hospitalized in ICU: A randomized clinical trial
Mitra Safa, Shahid Beheshti University of Medical Sciences, Iran (Islamic Republic of)
Title : Precision Treatment of Alzheimer's
Boris Tankhilevich, Magtera, Inc., United States